HOME >> BIOLOGY >> NEWS
Enzyme once thought harmful to Alzheimers patients now appears key to future treatment

March 12, 2002 -- Bethesda, MD -- The four million Americans who have been diagnosed with Alzheimers disease (AD) experience symptoms which include progressive mental deterioration, confusion, a loss of memory and an inability to calculate the simplest of numbers. This may be due to the fact that people with Alzheimer's have fewer brain cells and less of some important neurotransmitters than people without the disease.

The Importance of Galanin
Previous research has established that a substance called galanin is associated with learning and memory and is involved in brain function, and disorders such as epilepsy. When a nerve is cut or injured, the neuron produces extra galanin, possibly to repair or modulate the damage. The production of galanin may be one way that the body tries to repair nerve damage. Unfortunately, accepted literature states when the onset of AD occurs, galanin hyperinnervation (excessive supply) of nerve cells that employ acetylcholine as their neurotransmitter in the basal forebrain of AD patients occurs and depresses acetylcholine release and its inhibitory actions at other central nervous system sites.

Background
The majority of the scientific community believes this action is detrimental. This is due to a finding that AD wipes out many of the cholinergic neurons of the hippocampus; those that survive in the nucleus show elevated expression of galanin. However, a new study suggests that by virtue of its excitatory actions on cholinergic neurons, galanin may in fact play a compensatory role by enhancing the release of acetylcholine from remaining cholinergic basal forebrain neurons. This action might serve to delay the progression of Alzheimer's disease linked to a reduction in central cholinergic tone. This raises the possibility that induction of galanin by nerve growth factor may have a neuroprotective role.

The Study
To examine this theory, an investigation of the mechanism of action of this
'"/>

Contact: Donna Krupa
djkrupa1@aol.com
703-527-7357
American Physiological Society
14-Mar-2002


Page: 1 2 3

Related biology news :

1. Enzyme maintaining chromosome ends is linked to bone cancer recurrence, decreased survival
2. Enzyme activation appears key in helping internal clock tell night from day
3. Enzyme fully degrades mad cow disease prion
4. Enzyme revealed that is key to funguss ability to breach immune system
5. Enzyme discovery sheds light on causes of rare disease, cancer
6. Enzyme could overcome industrial bleaching waste problems
7. Enzyme controls good cholesterol
8. Enzyme discovery to benefit homeland security, industry
9. Enzyme could aid cancer fight
10. Enzyme mimetic reduces tissue damage in colitis animal study
11. Enzyme studies at Brookhaven Lab may lead to new antiviral agents

Post Your Comments:
(Date:6/19/2013)... paper published in the journal Polar Biology, researchers report using ... may be a new type of killer whale ( Orcinus ... unusual-looking killer whales stranded on a New Zealand beach and ... were also taken but it was almost 50 years before ... small white eye-patch and bulbous forehead, was documented alive in ...
(Date:6/19/2013)... -- MedNet Solutions , a global life sciences ... pleased to announce its participation in the 2013 DIA ... Boston .  This represents the 10 th ... eClinical solutions, has exhibited at this premier industry event. ... EDC , MedNet,s latest, easy-to-use eClinical technology platform.  ...
(Date:6/19/2013)... bred specifically for human consumption qualifies as a gluten-free ... disease (CD), scientists have confirmed in a study published ... . , Joyce Irene Boye and colleagues point ... United States alone have CD. They develop gastrointestinal and ... grains that contain gluten-related proteins. Boye,s team sought to ...
Breaking Biology News(10 mins):MedNet Solutions To Spotlight iMedNet EDC At The 49th DIA Annual Meeting 2
(Date:6/19/2013)... TX (PRWEB) June 19, 2013 Applied ... application report that details the measurement of sulfur in ... NEX QC+ high resolution benchtop EDXRF analyzer . The ... standard test method ISO 13032. This International Standard ... for the determination of sulfur content in automotive gasoline. ...
(Date:6/19/2013)... Diego, CA (PRWEB) June 19, 2013 ... pipettes, Pipette.com is now stocked with Simport’s Dropette® ... all aimed at the customer doing basic biology, chemistry ... work, and serology). , For over 35 years, Simport ... disposable plastic labware - products like the Simport Dropette®. ...
(Date:6/18/2013)... China Cord Blood Corporation (NYSE: CO ) ... blood collection, laboratory testing, hematopoietic stem cell processing, and ... financial results for the fourth quarter and full year ... Fourth Quarter of Fiscal 2013 Highlights ... increased by 33.3% to RMB133.0 million ($21.4 million) from ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 The ... opening of two new offices in Asia—one in Singapore ... will serve as RAPS’ Pan-Asia office , serving ... be more focused on audiences within China. , The ... its partnership with five Singapore government agencies to develop ...
Breaking Biology Technology:Rigaku Publishes New Application Note for Analysis of ULSD Per ISO 13032 2Leading Pipette Distributor Pipette.com Now Stocks Transfer Pipettes: Simport’s Dropette and Heathrow Scientific Disposable Plastic Transfer Pipettes 2China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 2China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 3China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 4China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 5China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 6China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 7China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 8China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 9China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 10China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 11China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 12China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 13RAPS Opens Offices in Singapore and China 2RAPS Opens Offices in Singapore and China 3
Cached News: